tldrdaily.news logo
Tag

Gene Editing Treatment

All articles tagged with #gene editing treatment

politics2 years ago

"Trump's Legal Maneuvers and FDA's Gene-Editing Breakthrough Dominate Headlines"

Former President Donald Trump announced that he will not testify in the New York civil fraud trial against him and his company, stating that he has "already testified to everything." The Doha Forum in Qatar resumes, with a focus on the war in Gaza and its impact on regional security. The FDA has approved the first gene-edited treatment for severe sickle cell disease. University of Pennsylvania president Liz Magill resigned after facing criticism for her congressional testimony on campus antisemitism. Chuck E. Cheese is getting rid of its animatronic band, causing nostalgia for some parents.

via NPR|
#chuck-e-cheese#doha-forum#donald-trump
business2 years ago

"FDA Approves CRISPR Gene Editing for Sickle Cell Treatment, Paving the Way for Breakthrough"

Shares of Crispr Therapeutics experienced volatility after the FDA approved the company's gene-editing treatment for sickle cell disease. The stock initially rallied but then fell over 8%. The treatment, developed by Crispr and co-developed by Vertex Pharmaceuticals, offers targeted and effective therapy for individuals with limited treatment options. The approval follows a previous approval by the U.K.'s regulatory agency. Crispr's stock is up nearly 50% year to date, closing at $64.54, while Vertex's stock dipped to $350.15.

via Investor's Business Daily|
#business#crispr-therapeutics#fda-approval
health2 years ago

"U.S. Approves Groundbreaking Gene-Editing Treatment for Sickle Cell Patients"

The U.S. is expected to approve exa-cel, a gene-editing treatment for sickle cell disease, by the end of this week. Developed by Vertex Pharmaceuticals and CRISPR Therapeutics, exa-cel uses CRISPR technology to edit a patient's DNA and alleviate the symptoms of sickle cell disease. The treatment has shown promising results in clinical trials, significantly reducing pain crises for patients. However, the lengthy treatment timeline, potential infertility risks, limited availability, and high cost (estimated at $2 million per patient) pose challenges for widespread adoption. Despite these obstacles, patients like Joe Tsogbe, who received exa-cel, have experienced life-changing improvements and are hopeful for a better future.

via CNBC|
#crispr#exa-cel#gene-editing-treatment